5 completed, 4 terminated, 1 withdrawn. 10 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Terminated 4, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow motesanib diphosphate: new trials by email Literature Review of motesanib diphosphate trials Research Report on motesanib diphosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer Ixabepilone, Capecitabine, Motesanib - Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-01 | 2025-05-02 | |
| AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors AMG 706, octreotide - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor | Phase 2 | Completed | Eastern Cooperative Oncology Group | 46 | 2008-11-07 | 2023-07-05 |
| AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer motesanib diphosphate - Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Terminated | Gynecologic Oncology Group | 23 | 2007-12-01 | 2018-01-11 |
| A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC Bevacizumab, AMG 706, Paclitaxel - Advanced Non-squamous NSCLC | Phase 2 | Terminated | Amgen | 186 | 2007-01-31 | 2018-01-04 |
| A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer AMG 706 placebo, Bevacizumab, AMG 706 - Breast Neoplasms, Breast Tumors | Phase 2 | Terminated | Amgen | 282 | 2006-12-01 | 2015-10-15 |
| An Open Label Treatment Extension Study of AMG 706 AMG 706 - Solid Tumors | Phase 2 | Terminated | Amgen | 94 | 2005-12-01 | 2015-10-15 |
| Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors AMG 706 - Advanced Gastrointestinal Stromal Tumor | Phase 2 | Completed | Amgen | 35 | 2005-11-01 | 2014-02-27 |
| A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer AMG 706 - Thyroid Cancer | Phase 2 | Completed | Amgen | 184 | 2005-07-01 | 2013-10-09 |
| Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Panitumumab, Motesanib diphosphate, Paclitaxel - Lung Cancer, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | Amgen | 51 | 2005-01-01 | 2016-03-24 |
| Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) AMG 706 - Gastrointestinal Cancer | Phase 2 | Completed | Amgen | 138 | 2004-10-01 | 2013-04-29 |
Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma, Follicular (1) · Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Carcinoma, Medullary (1) · Carcinoma, Ovarian Epithelial (1) · Fallopian Tube Neoplasms (1) · Gastrinoma (1) · Gastrointestinal Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Glucagonoma (1) · Insulinoma (1) · Lung Neoplasms (1) · Neoplasms (1)
Amgen (7) · Eastern Cooperative Oncology Group (1) · Gynecologic Oncology Group (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (3)
Edith Mitchell, MD (1) · Mary Mulcahy, MD (1) · Russell J. Schilder, MD (1)
PMID 20838998, PMID 18596272, PMID 20739388, PMID 21429799, PMID 25314641, PMID 29853660
U10CA023318 (1)